These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 29110622)

  • 1. Recent Development of Sulfonyl or Sulfonamide Hybrids as Potential Anticancer Agents: A Key Review.
    Rakesh KP; Wang SM; Leng J; Ravindar L; Asiri AM; Marwani HM; Qin HL
    Anticancer Agents Med Chem; 2018; 18(4):488-505. PubMed ID: 29110622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Podophyllotoxin derivatives as an excellent anticancer aspirant for future chemotherapy: A key current imminent needs.
    Zhang X; Rakesh KP; Shantharam CS; Manukumar HM; Asiri AM; Marwani HM; Qin HL
    Bioorg Med Chem; 2018 Jan; 26(2):340-355. PubMed ID: 29269253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and identification of heteroaromatic N-benzyl sulfonamides as potential anticancer agents.
    Hopkins MD; Abebe FA; Scott KA; Ozmer GL; Sheir AA; Schroeder LJ; Sheaff RJ; Lamar AA
    Org Biomol Chem; 2019 Sep; 17(36):8391-8402. PubMed ID: 31469373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, anticancer and radiosensitizing evaluation of some novel sulfonamide derivatives.
    Ghorab MM; Ragab FA; Heiba HI; El-Gazzar MG; Zahran SS
    Eur J Med Chem; 2015 Mar; 92():682-92. PubMed ID: 25618015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of dehydroabietic acid sulfonamide based derivatives as selective matrix metalloproteinases inactivators that inhibit cell migration and proliferation.
    Huang RZ; Liang GB; Huang XC; Zhang B; Zhou MM; Liao ZX; Wang HS
    Eur J Med Chem; 2017 Sep; 138():979-992. PubMed ID: 28756264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel 1,4-naphthoquinone-based sulfonamides: Synthesis, QSAR, anticancer and antimalarial studies.
    Pingaew R; Prachayasittikul V; Worachartcheewan A; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
    Eur J Med Chem; 2015 Oct; 103():446-59. PubMed ID: 26397393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and structure-activity relationship study of water-soluble carbazole sulfonamide derivatives as new anticancer agents.
    Liu Y; Wu Y; Sun L; Gu Y; Hu L
    Eur J Med Chem; 2020 Apr; 191():112181. PubMed ID: 32113125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent development of azole-sulfonamide hybrids with the anticancer potential.
    Zhao C; Liu Y; Cui Z
    Future Med Chem; 2024; 16(12):1267-1281. PubMed ID: 38989985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artemisinin-derived hybrids and their anticancer activity.
    Gao F; Sun Z; Kong F; Xiao J
    Eur J Med Chem; 2020 Feb; 188():112044. PubMed ID: 31945642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anticancer therapeutic potential of pyrimidine-sulfonamide hybrids.
    Zhang P; Shi C; Dong T; Song J; Du G
    Future Med Chem; 2024; 16(9):905-924. PubMed ID: 38624011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in isatin hybrids as potential anticancer agents.
    Ding Z; Zhou M; Zeng C
    Arch Pharm (Weinheim); 2020 Mar; 353(3):e1900367. PubMed ID: 31960987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and anticancer activity of some novel trifluoromethylquinolines carrying a biologically active benzenesulfonamide moiety.
    Al-Dosari MS; Ghorab MM; Alsaid MS; Nissan YM; Ahmed AB
    Eur J Med Chem; 2013 Nov; 69():373-83. PubMed ID: 24077528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinazoline-sulfonamides as potential antitumor agents: synthesis and biological testing.
    Alafeefy AM; Alqasoumi SI; Ashour AE; Alshebly MM
    J Enzyme Inhib Med Chem; 2013 Apr; 28(2):375-83. PubMed ID: 22468752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, biological evaluation and molecular modeling of dihydropyrazole sulfonamide derivatives as potential COX-1/COX-2 inhibitors.
    Chen Z; Wang ZC; Yan XQ; Wang PF; Lu XY; Chen LW; Zhu HL; Zhang HW
    Bioorg Med Chem Lett; 2015 May; 25(9):1947-51. PubMed ID: 25866240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coumarin-containing hybrids and their anticancer activities.
    Zhang L; Xu Z
    Eur J Med Chem; 2019 Nov; 181():111587. PubMed ID: 31404864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isatin-azole hybrids and their anticancer activities.
    Hou Y; Shang C; Wang H; Yun J
    Arch Pharm (Weinheim); 2020 Jan; 353(1):e1900272. PubMed ID: 31691360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, single-crystal and preliminary antitumor activity of novel arenesulfonylimidazolidin-2-ones.
    Abdel-Aziz AA; El-Azab AS; El-Subbagh HI; Al-Obaid AM; Alanazi AM; Al-Omar MA
    Bioorg Med Chem Lett; 2012 Mar; 22(5):2008-14. PubMed ID: 22318157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uncovering the Potential of Chalcone-Sulfonamide Hybrids: A Systematic Review on Their Anticancer Activity and Mechanisms of Action.
    Souza JMT; Silva SANM; Rocha RBD; Machado FDS; Marinho Filho JDB; Araújo AJ
    Cell Biochem Funct; 2024 Sep; 42(7):e70001. PubMed ID: 39425507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, Biological Evaluation, and Docking of Dihydropyrazole Sulfonamide Containing 2-hydroxyphenyl Moiety: A Series of Novel MMP-2 Inhibitors.
    Wang PF; Qiu HY; Baloch SK; Gong HB; Wang ZC; Zhu HL
    Chem Biol Drug Des; 2015 Dec; 86(6):1405-10. PubMed ID: 26061284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfonamide derivatives as potential anti-cancer agents and their SARs elucidation.
    Wan Y; Fang G; Chen H; Deng X; Tang Z
    Eur J Med Chem; 2021 Dec; 226():113837. PubMed ID: 34530384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.